Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"

Ellen M. Mowry, Dennis Bourdette

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"'. Together they form a unique fingerprint.